Exousia Bio, Inc. (LMMY)

SEC fundamentals · as filed in 10-Q FY2026, period ended Feb 28, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$22.1M
Stockholders' Equity
$21.8M
Cash & Equivalents
$0
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Feb 28, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Feb 28, 2026, Exousia Bio, Inc. reported revenue of $0, net income of $0, and total assets of $22.1M. Every figure below is taken directly from Exousia Bio, Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$3,750$51,395
FY2024$11,500-$25,807
FY2023$0-$56,421

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
10-QJun 16, 2026on EDGAR ↗
NT 10-QApr 14, 2026on EDGAR ↗
10-QMar 17, 2026on EDGAR ↗
NT 10-QJan 15, 2026on EDGAR ↗
8-KNov 17, 2025on EDGAR ↗
10-QNov 17, 2025on EDGAR ↗
10-KOct 17, 2025on EDGAR ↗
10-QApr 24, 2025on EDGAR ↗
10-QJan 10, 2025on EDGAR ↗
8-KDec 17, 2024on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Feb 28, 2026 · 10-Q

Total Assets$22.1Msource ↗
Stockholders’ Equity$21.8Msource ↗
Cash & Equivalents$0source ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Feb 28, 2026

Revenue$0source ↗
Net Income$0source ↗
Operating Income$0source ↗
Gross Profit$0source ↗
Cost of Revenue$0source ↗
R&D Expense—source ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Feb 28, 2026

EPS (diluted)—source ↗
EPS (basic)—source ↗
Shares Outstanding52.5Msource ↗
Cash from Operations$0source ↗
Cash from Financing$0source ↗
Cash from Investing$0source ↗

Restatement history

Point-in-time

No material restatements detected across 81 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches LMMY’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Get a free API key →See plans

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/LMMY

MCP tool: get_sec_fundamentals ticker=LMMY

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/LMMY/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=LMMY as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/LMMY/history

MCP tool: get_fundamentals_history ticker=LMMY

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/financial-health/LMMY

MCP tool: get_financial_health ticker=LMMY

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.